Scynexis SCYX
NASDAQ SCYX
$5.24 +0.09 (+1.84%)
At close: Aug 20, 2026 · 1:19 PM UTC

Scynexis (SCYX) Cash from Investing Activities (2013 - 2026)

Scynexis' (SCYX) quarterly Cash from Investing Activities came in at -$525000.0 in Q1 2026, down 104.22% YoY from $12.4 million in Q1 2025, and up 95.56% on a QoQ basis from -$11.8 million in Q4 2025.

Scynexis (SCYX) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Scynexis (SCYX) has 14 years of Cash from Investing Activities data on file, last reported at -$525000.0 in Q1 2026.

  • Quarterly Cash from Investing Activities fell 104.22% year-over-year to -$525000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.3 million (down 13.66% YoY) and the FY2025 annual result came in at $24.3 million, up 295.22% from the prior year.
  • Cash from Investing Activities grew to -$525000.0 in Q1 2026, from -$11.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $12.4 million in Q1 2025 to a low of -$27.4 million in Q3 2022.
  • A 5-year average of -$2.3 million and a median of -$267000.0 in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 8000.59% — and 2025, when it surged 721.65%.
  • Tracing SCYX's Cash from Investing Activities over 5 years: stood at -$27.4 million in 2022, then surged by 92.14% to -$2.2 million in 2023, then dropped by 21.61% to -$2.6 million in 2024, then tumbled by 351.82% to -$11.8 million in 2025, then jumped by 95.56% to -$525000.0 in 2026.
  • The last three Cash from Investing Activities figures came in at -$525000.0 (Q1 2026), -$11.8 million (Q4 2025), and $12.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.33 Bn 2.15 Bn -491.00 Mn
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 22.15 Bn 19.48 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 11.74 Bn 11.21 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Scynexis 62.02 Mn -52.68 Mn - -24.76 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -24.76 Mn
Jun 30, 2026 -24.76 Mn
Mar 31, 2026 -525,000.00
Mar 31, 2026 -525,000.00
Dec 31, 2025 -11.82 Mn
Dec 31, 2025 -11.82 Mn
Sep 30, 2025 12.42 Mn
Sep 30, 2025 12.42 Mn
Jun 30, 2025 11.27 Mn
Jun 30, 2025 11.27 Mn
Mar 31, 2025 12.44 Mn
Mar 31, 2025 12.44 Mn
Dec 31, 2024 -2.62 Mn
Dec 31, 2024 -2.62 Mn
Sep 30, 2024 1.94 Mn
Sep 30, 2024 1.94 Mn
Jun 30, 2024 1.37 Mn
Jun 30, 2024 1.37 Mn
Mar 31, 2024 5.45 Mn
Mar 31, 2024 5.45 Mn